Clinical Trial Management Systems (CTMS) - Global Market Trajectory & Analytics

Global Clinical Trial Management Systems (CTMS) Market to Reach $1.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Clinical Trial Management Systems (CTMS) estimated at US$728.8 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 11.9% over the period 2020-2027. Enterprise CTMS, one of the segments analyzed in the report, is projected to record 12.8% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Site CTMS segment is readjusted to a revised 9.9% CAGR for the next 7-year period.



The U.S. Market is Estimated at $215.1 Million, While China is Forecast to Grow at 11.4% CAGR

The Clinical Trial Management Systems (CTMS) market in the U.S. is estimated at US$215.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$279.7 Million by the year 2027 trailing a CAGR of 11.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.6% and 10% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.

Select Competitors (Total 62 Featured):

• ArisGlobal LLC
• BioClinica Inc.
• Bio-Optronics Inc.
• DSG Inc.
• eResearch Technology Inc.
• IBM Watson Health
• Medidata Solutions
• MedNet Solutions
• Nextrials Inc.
• Oracle Corp.
• PAREXEL International Corp.
• Trial By Fire Solutions LLC
• Veeva Systems Inc.